PT833903E - Vacina multivalente de coroanavirus de bovino e metodo para tratar a infeccao decoronavirus de bovino - Google Patents
Vacina multivalente de coroanavirus de bovino e metodo para tratar a infeccao decoronavirus de bovinoInfo
- Publication number
- PT833903E PT833903E PT96923275T PT96923275T PT833903E PT 833903 E PT833903 E PT 833903E PT 96923275 T PT96923275 T PT 96923275T PT 96923275 T PT96923275 T PT 96923275T PT 833903 E PT833903 E PT 833903E
- Authority
- PT
- Portugal
- Prior art keywords
- bovine
- bcv
- multivalent
- cattle
- vaccine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/826—Viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48961495A | 1995-06-12 | 1995-06-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT833903E true PT833903E (pt) | 2004-11-30 |
Family
ID=23944554
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT96923275T PT833903E (pt) | 1995-06-12 | 1996-06-07 | Vacina multivalente de coroanavirus de bovino e metodo para tratar a infeccao decoronavirus de bovino |
Country Status (10)
Country | Link |
---|---|
US (1) | US5916570A (pt) |
EP (1) | EP0833903B1 (pt) |
AT (1) | ATE274579T1 (pt) |
AU (1) | AU705186B2 (pt) |
CA (1) | CA2224309C (pt) |
DE (1) | DE69633233T2 (pt) |
DK (1) | DK0833903T3 (pt) |
ES (1) | ES2224172T3 (pt) |
PT (1) | PT833903E (pt) |
WO (1) | WO1996041874A1 (pt) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998040097A2 (en) * | 1997-03-10 | 1998-09-17 | Bayer Corporation | Bovine respiratory and enteric coronavirus as a vaccine |
AU2001264802A1 (en) | 2000-05-21 | 2001-12-03 | University Of North Carolina At Chapel Hill | Assembly of large viral genomes and chromosomes from subclones |
US6974577B2 (en) * | 2001-02-04 | 2005-12-13 | Novartris Ag | Inactivated bovine scours vaccines, processes and method of preventing bovine scours |
US7906311B2 (en) * | 2002-03-20 | 2011-03-15 | Merial Limited | Cotton rat lung cells for virus culture |
GB0217434D0 (en) * | 2002-07-27 | 2002-09-04 | Royal Vetinary College | Biological material |
GB0315323D0 (en) * | 2003-07-01 | 2003-08-06 | Royal Veterinary College | Vaccine composition |
US9023366B2 (en) | 2003-07-01 | 2015-05-05 | The Royal Veterinary College | Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD) |
WO2011008958A1 (en) * | 2009-07-17 | 2011-01-20 | The Board Of Regents For Oklahoma State University | Supralingual vaccines and applicators |
WO2011056175A1 (en) | 2009-11-06 | 2011-05-12 | Intervet International B.V. | Methods of immunizing pregnant heifers at three months of gestation |
KR102243374B1 (ko) * | 2019-09-30 | 2021-04-22 | 대한민국 | 소 코로나바이러스, 소 로타바이러스 및 소 바이러스성설사병바이러스에 대한 백신 조성물 |
KR102234525B1 (ko) * | 2020-08-28 | 2021-03-30 | 안병철 | 송아지의 점막관련 전염성 질병을 예방 또는 치료하기 위한 혈청의 제조방법, 상기 방법에 의해 제조된 혈청 및 이의 용도 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3839556A (en) * | 1969-11-28 | 1974-10-01 | Univ Nebraska | Calf diarrhea virus vaccine and processes |
US3838004A (en) * | 1970-11-17 | 1974-09-24 | Univ Nebraska | Calf diarrhea virus vaccine and processes |
US3869547A (en) * | 1971-11-10 | 1975-03-04 | Univ Nebraska | Calf diarrhea virus vaccine and processes |
US3914408A (en) * | 1973-10-12 | 1975-10-21 | Univ Nebraska | Vaccine for neonatal calf diarrhea |
-
1996
- 1996-06-07 DK DK96923275T patent/DK0833903T3/da active
- 1996-06-07 PT PT96923275T patent/PT833903E/pt unknown
- 1996-06-07 ES ES96923275T patent/ES2224172T3/es not_active Expired - Lifetime
- 1996-06-07 WO PCT/US1996/009979 patent/WO1996041874A1/en active IP Right Grant
- 1996-06-07 CA CA 2224309 patent/CA2224309C/en not_active Expired - Lifetime
- 1996-06-07 AT AT96923275T patent/ATE274579T1/de active
- 1996-06-07 EP EP19960923275 patent/EP0833903B1/en not_active Expired - Lifetime
- 1996-06-07 DE DE1996633233 patent/DE69633233T2/de not_active Expired - Lifetime
- 1996-06-07 AU AU63832/96A patent/AU705186B2/en not_active Ceased
-
1997
- 1997-02-04 US US08/795,294 patent/US5916570A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0833903B1 (en) | 2004-08-25 |
DK0833903T3 (da) | 2005-01-03 |
EP0833903A4 (en) | 1999-03-24 |
ES2224172T3 (es) | 2005-03-01 |
ATE274579T1 (de) | 2004-09-15 |
CA2224309A1 (en) | 1996-12-27 |
US5916570A (en) | 1999-06-29 |
EP0833903A1 (en) | 1998-04-08 |
AU705186B2 (en) | 1999-05-20 |
AU6383296A (en) | 1997-01-09 |
DE69633233D1 (de) | 2004-09-30 |
WO1996041874A1 (en) | 1996-12-27 |
DE69633233T2 (de) | 2005-08-11 |
CA2224309C (en) | 2011-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2176232T3 (es) | Vacuna adecuada para ser utilizada en la prevencion y tratamiento de la infeccion por helicobacter. | |
PT815235E (pt) | Vacinas para peste | |
UY26724A1 (es) | Métodos y composiciones para tratar el virus de la hepatitis c | |
ATE271063T1 (de) | Purin-l-nukleoside, deren analoga und verwendungen | |
ES2173300T3 (es) | Vacunas de virus vivos prrs de baja patogenicidad y metodos para su preparacion. | |
PT833903E (pt) | Vacina multivalente de coroanavirus de bovino e metodo para tratar a infeccao decoronavirus de bovino | |
UA66744C2 (en) | 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections | |
WO1996006620A3 (en) | Lipid analogs for treating viral infections | |
UA40571C2 (uk) | Мутант коров'ячого вірусу герпесу типу 1 (bhv-1), композиція вакцини для вакцинації тварин для захисту їх від bhv-1, композиція вакцини для вакцинації тварин для захисту їх від патогена | |
ATE79548T1 (de) | Herpes simplex virus subunitimpfstoff. | |
ATE103297T1 (de) | Peptid, immunogene zusammensetzung und impfstoff oder medizinische zubereitung, eine methode zur immunisierung eines saeugetieres gegen lhrh und methode zur verbesserung von mea. | |
ATE226829T1 (de) | Pharmazeutische zusammensetzung, enthaltend serum-amyloid p-komponenten, zur prophylaxe und therapie von viralen infektionen sowie kit zur detektionvon komplexen zwischen solchen zusammensetzungen und viralen komponenten | |
BG102809A (en) | Vaccine against the reproductive and respiratory syndrome in pigs | |
ATE416788T1 (de) | Verwendung von pflanzen-öl-körper in impfstoffverabreichungsysteme | |
LU90204I2 (fr) | Anatoxine diphtérique anatoxine tétanique trois antigènes coquelucheux purifiés (toxine pertussique tp hémagglutinine filamenteuse (haf) et pertactine (protéine de membrane externe 69 kd) et le principal antigène de surface du virus de l'hépatite b (vhb) purfié (infanrix hepb) et ses dérivés pharmaceutiquement acceptables | |
Edwards et al. | Evidence for an immunocompromising effect of bovine pestivirus on bovid herpesvirus 1 vaccination | |
BR0109928A (pt) | Uso de um herpes vìrus atenuado, e, método para estimular uma resposta imune em um indivìduo humano ou animal, ou para tratar ou prevenir uma infecção patogênica ou câncer em um indivìduo humano ou animal | |
ES2079851T3 (es) | Uso de il-4 para mejorar la respuesta inmunitaria frente a inmunogenos en vacunas. | |
JP3109886B2 (ja) | 経鼻接種用ワクチン | |
AR010568A1 (es) | Polipeptido, composicion de vacuna, uso del polipeptido en la fabricacion de una composicion, y metodo para producir en un mamifero una respuestainmuno-protectora contra la infeccion de helicobacter pylori | |
PT1156791E (pt) | Bupropiona para tratar doencas virais | |
HUP9700975A2 (hu) | Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok | |
ES2060740T3 (es) | Vacunas de virus vivos para la enfermedad de newcastle. | |
Grachev | Long-term use of oral poliovirus vaccine from Sabin strains in the Soviet Union | |
DK0858345T3 (da) | Anvendelse af muteiner af vildtypecytokiner som immunogener |